Nefazodone Hydrochloride (AvKARE, Inc.)
Welcome to the PulseAid listing for the Nefazodone Hydrochloride drug offered from AvKARE, Inc.. This Serotonin Reuptake Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
NON-PROPRIETARY NAME: | Nefazodone Hydrochloride |
SUBSTANCE NAME: | NEFAZODONE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Serotonin Reuptake Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-07-30 |
END MARKETING DATE: | 0000-00-00 |
Nefazodone Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Nefazodone Hydrochloride from AvKARE, Inc. |
LABELER NAME: | AvKARE, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2013-07-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42291-627_9e0e0d0e-1839-88ba-a57b-78fc5a7938b2 |
PRODUCT NDC: | 42291-627 |
APPLICATION NUMBER: | ANDA076037 |
Other NEFAZODONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: